GI Stool Testing Market Size

GI Stool Testing Market Size

GI Stool Testing Market size was valued at around USD 600.1 million in 2022 and is estimated to reach over USD 1.2 billion by the end of 2032. The increasing prevalence of gastrointestinal diseases is anticipated to drive the market growth globally.

To get key market trends

  Download Free Sample

The rising incidence of colorectal cancer (CRC) is owing to factors including unhealthy lifestyle, diabetes, and ageing population, among others thereby driving market expansion. For instance, according to the reports published by the American Society of Clinical Oncology (ASCO), in 2020, approximately around 1,880,725 individuals were diagnosed with colorectal cancer across the globe

GI stool testing tests delivers certain clinical benefits over conventional diagnostic procedures, such as rapid specimen handling, simpler sample requirements, increased automation, and rapid results. As a result, the demand for GI stool testing is proliferating, especially in the emerging economies that possess immense market value. Moreover, the increased usage and demand for these testing procedures in hospital settings is expected to develop business growth opportunities.

GI stool testing products are utilized for the diagnosis of gastrointestinal diseases comprising infection, inflammatory bowel disease, gastroesophageal reflux disease (GERD), and cancer among others. These testing products include an occult blood test, parasites test, bacteria test, and fecal biomarkers test among others that are employed in the detection and treatment of certain gastrointestinal conditions.

However, gastrointestinal diseases can be diagnosed with different testing techniques comprising GI stool testing. These tests require accurate operational skills for precise diagnosis to evaluate appropriate treatment. Thus, the lack of skilled professionals in countries with limited healthcare resources can hamper the disease testing rate, thereby impacting the industry revenue.